Assertio Holdings, Inc. (ASRT) Financials

ASRT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 380.0 million 187.2 million
2023-06-30 405.2 million 150.9 million
2023-03-31 414.3 million 163.6 million
2022-12-31 413.9 million 188.2 million

ASRT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 2.6 million 1.9 million
2023-06-30 17.9 million 2.2 million
2023-03-31 22.6 million 2.4 million
2022-12-31 26.4 million 2.4 million

ASRT Net Income

No data available :(

ASRT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 76.9 million - -
2023-06-30 70.2 million - -
2023-03-31 68.6 million - -
2022-12-31 64.9 million - -

ASRT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 81.7 million
2023-06-30 70.1 million
2023-03-31 51.0 million
2022-12-31 67.1 million

ASRT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.3 million 21.0 million -
2023-06-30 703000 503000 16.8 million -
2023-03-31 105000 - 16.9 million -
2022-12-31 274000 - 10.3 million 3.4 million

ASRT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 35.6 million 7.1 million
2023-06-30 41.0 million 4.8 million
2023-03-31 42.5 million 5.5 million
2022-12-31 50.4 million 6.0 million

ASRT

Price: $0.83

52 week price:
0.75
8.01

Earnings Per Share: -4.67 USD

P/E Ratio: -0.29

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 856800

Market Capitalization: 86.2 million

Links: